285 related articles for article (PubMed ID: 3310952)
21. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
Wells BG; Evans RL; Ereshefsky L; Antal EJ; Lobeck F; Rawls WN; Hamann G; Grimmig J; Smith RB
J Clin Psychiatry; 1988 Oct; 49(10):394-9. PubMed ID: 3049560
[TBL] [Abstract][Full Text] [Related]
22. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
[TBL] [Abstract][Full Text] [Related]
23. Comparative studies of pharmacotherapy for school refusal.
Bernstein GA; Garfinkel BD; Borchardt CM
J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
[TBL] [Abstract][Full Text] [Related]
25. A double blind study in out-patients with primary non-agitated depression treated with imipramine in combination with placebo, diazepam or dixyrazine.
Feet PO; Larsen S; Robak OH
Acta Psychiatr Scand; 1985 Oct; 72(4):334-40. PubMed ID: 3907277
[TBL] [Abstract][Full Text] [Related]
26. An outpatient evaluation of phenelzine and imipramine.
Davidson J; Raft D; Pelton S
J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
[TBL] [Abstract][Full Text] [Related]
27. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Dawson GW; Jue SG; Brogden RN
Drugs; 1984 Feb; 27(2):132-47. PubMed ID: 6141930
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Taylor CB; Hayward C; King R; Ehlers A; Margraf J; Maddock R; Clark D; Roth WT; Agras WS
J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
[TBL] [Abstract][Full Text] [Related]
29. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
Stark P; Hardison CD
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
[TBL] [Abstract][Full Text] [Related]
30. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
[TBL] [Abstract][Full Text] [Related]
31. Imipramine treatment for chronic depression.
Kocsis JH; Frances AJ; Voss C; Mann JJ; Mason BJ; Sweeney J
Arch Gen Psychiatry; 1988 Mar; 45(3):253-7. PubMed ID: 3277579
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
[TBL] [Abstract][Full Text] [Related]
33. Withdrawal reactions to diazepam in combined imipramine/diazepam treatment of primary nonagitated depressed outpatients.
Feet PO; Larsen S; Lillevold PE; Robak OH
Acta Psychiatr Scand; 1988 Sep; 78(3):341-7. PubMed ID: 3057815
[TBL] [Abstract][Full Text] [Related]
34. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
35. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
36. A controlled clinical trial of alprazolam for the treatment of anxiety.
Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
[TBL] [Abstract][Full Text] [Related]
37. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
Rickels K; Feighner JP; Smith WT
Arch Gen Psychiatry; 1985 Feb; 42(2):134-41. PubMed ID: 2858187
[TBL] [Abstract][Full Text] [Related]
38. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
[TBL] [Abstract][Full Text] [Related]
39. Alprazolam compared to diazepam and placebo in the treatment of anxiety.
Aden GC; Thein SG
J Clin Psychiatry; 1980 Jul; 41(7):245-8. PubMed ID: 6993446
[TBL] [Abstract][Full Text] [Related]
40. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
Rosenberg R; Bech P; Mellergård M; Ottosson JO
Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
